The abstract is read at the publisher; the summary is JClub's.
SAPHE-R, a non-invasive rule using liver stiffness, platelets, and ALBI grade, missed only 4.0% of varices in 598 Italian HCC patients with cACLD.
- Why it matters: Baveno VI criteria may not reliably avoid endoscopy in hepatocellular carcinoma, where routine upper gastrointestinal endoscopy could be unnecessary if a safer rule-out strategy exists.
- What they did: Using logistic regression on ITA.LI.CA patients with LSM, blood tests, and UGE within 6 months, the authors built SAPHE-R (LSM ≤16 kPa, platelets ≥160×10^9/L, ALBI grade 1) and validated it by bootstrap and in a Vienna cohort.
- The result: In the derivation cohort, Baveno VI missed 8.5% of varices and 6.0% of high-risk varices while sparing 31.1% of UGE; SAPHE-R missed 4.0% of varices (HRV 3.0%) and spared 17.6% of UGE, with similar performance in validation (4.8% missed).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.